InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
T+90 胜率
100%
T+90 平均收益
+18.9%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the detailed record of transactions filed by Blackley Seth, 董事长兼首席执行官. Officer active across 1 company, notably Evolent Health, Inc.. In total, 19 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €461k. History available since 15 October 2021. The latest transaction was filed on 1 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Blackley Seth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
10,297 股@ US$5.740.0093% mcap1.7% 占其流量Class A Common StockSEC:0001628908-26-000070:1
446,102 股0Class A Common StockSEC:0001628908-26-000070:0
9,537 股@ US$3.251.0% 占其流量Class A Common StockSEC:0001628908-26-000023:0
67,150 股0Class A Common StockSEC:0001628908-25-000107:0
55,225 股@ US$9.0115.5% 占其流量Class A Common StockSEC:0001628908-25-000044:0
标准退出：2025年6月4日 (T+90)
28,535 股@ US$8.998.3% 占其流量Class A Common StockSEC:0001628908-25-000024:0
100,000 股@ US$6.8720.7% 占其流量Class A Common StockSEC:0001628908-24-000096:0
29,096 股0Class A Common StockSEC:0001628908-24-000032:0
206,209 股0Class A Common StockSEC:0001628908-24-000025:0
280,000 股0Class A Common StockSEC:0001628908-23-000185:0
33,011 股@ US$3.843.9% 占其流量Class A Common StockSEC:0001628908-23-000107:0
75,931 股@ US$3.848.9% 占其流量Class A Common StockSEC:0001628908-23-000105:0
360,000 股0Class A Common StockSEC:0001628908-23-000047:0
59,002 股0Class A Common StockSEC:0001628908-23-000043:0
206,211 股0Class A Common StockSEC:0001628908-23-000017:0
75,000 股@ US$3.849.4% 占其流量Class A Common StockSEC:0001628908-22-000156:0
286,867 股0Class A Common StockSEC:0001628908-22-000045:0
64,991 股0Class A Common StockSEC:0001628908-22-000035:0
150,000 股@ US$3.8419.4% 占其流量Class A Common StockSEC:0001628908-21-000135:0
19 条申报中的 19 条
About Blackley Seth
Blackley Seth is Président-Directeur Général and Chief Executive Officer of Evolent Health, Inc. The 19 filings concern Evolent Health, Inc., with EUR 460936 of buys and EUR 0 of sells over the covered period, from 2021-10-19 to 2026-07-06, and the most frequent transaction nature is option exercise.
